Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.
about
Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients.In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory ArthritisA CD8α- Subset of CD4+ SLAMF7+ Cytotoxic T Cells is Expanded in Patients with IgG4-Related Disease and Decreases following Glucocorticoid Treatment.
P2860
Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Repeated decrease of CD4+ T-ce ...... cycles of rituximab treatment.
@en
Repeated decrease of CD4+ T-ce ...... cycles of rituximab treatment.
@nl
type
label
Repeated decrease of CD4+ T-ce ...... cycles of rituximab treatment.
@en
Repeated decrease of CD4+ T-ce ...... cycles of rituximab treatment.
@nl
prefLabel
Repeated decrease of CD4+ T-ce ...... cycles of rituximab treatment.
@en
Repeated decrease of CD4+ T-ce ...... cycles of rituximab treatment.
@nl
P2093
P2860
P1476
Repeated decrease of CD4+ T-ce ...... cycles of rituximab treatment.
@en
P2093
Clément Bahuaud
Denis Mulleman
Gilles Thibault
Hervé Watier
Hsueh Cheng Sung
Matthieu Lavielle
Philippe Goupille
P2860
P2888
P356
10.1186/S13075-016-1152-5
P577
2016-10-28T00:00:00Z